Réintégrés enfin après 560 jours SANS AUCUN DROIT !
Le gouvernement Francais avait crée un statut spécial pour les soignants, les pompiers et même certains personnels hospitaliers ou médico-sociaux NON vaccinés : SUSPENSION !
Pas de salaire, aucune indemnité, pas de revenu minimum, pas de droit au chômage, pas de droit à la formation, pas de cotisation retraite, pas de licenciement consensuel. Jamais l'Etat n'était allé aussi loin dans une sanction au mépris même du fait connu et reconnu que la vaccination ne protégeait absolument pas de la contamination par le Sars Cov2. Présentée comme une mesure sanitaire, elle n'était que politique. "Ethique" ont ils même osé dire alors qu'imposer ces vaccins, en phase expérimentale de l'aveu même de leurs fabricants, dérogeait à l'ensemble des droits et des chartes en vigueur depuis Nuremberg ...
Ces suspendus ont subi une mort sociale cruelle, lente, injuste et une indignation sans précedent dans l'indifférence quasi générale.
560 jours ! PLUS JAMAIS CA... Mais on a juré nos grands Dieux tant de fois que ces 3 mots sont à jamais galvaudés !
Merci pour vos avis quels qu'ils soient à condition qu'ils restent respectueux.
DEAR FRIENDS I WOULD LIKE TOWISH YOU MARY CHRISTMAS AND HAPPY NEW YEAR
MY DEAR FRIENDS I WISH YOU THE BEST MARY CHRISTMAS AND HAPPY NEW YEAR AND A LOND SLEEPING EVERY NIGHT 7-8 YOURS
BE CAREFULL AND REMEMBER THE VACCINES ARE THE BLESSIG OF THE WORLD ANNA MARIA SKURATOWICZ-KUBICA HERBU ZADORA FROM POLANA INTERNIST DIABETOLOGIST
COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis
Among individuals who recovered from a first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, vaccination was associated with a “significant and substantial” reduction of the risk of both reinfection and severe coronavirus disease 2019 (COVID-19), according to a meta-analysis published in Frontiers in Medicine.
Files (141 downloads):
-
Hello dear colleague! Not lymphoma, but gastric, thyroid, pancreas and colon maligan neoplasia, I've already had diagnoses after Pfizer and Astrazenica vaccines.
__reactions__ -
Of course, the injection of mRNA is a gene therapy. Robert Malone was clear about this. See for example his article: https://rwmalonemd.substack.com/p/when-is-mrna-not-really-mrnaSee also:"Genetic vaccines are gene therapy products, all the regulations, laws, and safety protections should be called for and pointed out when missing in the discussion on the next steps to be taken on mRNA genetic vaccines."https://petermcculloughmd.substack.com/p/mrna-vaccine-or-gene-therapy-the?publication_id=1119676&post_id=130975965&isFreemail=falseThe misslabeling of a gene therapy as vaccine was intentional. It was part of the plan. The reasons are obvious. As was the new WHO definition for a pandemic situation.
__reactions__ -
Presentations were given by the FDA, CDC, Pfizer, Moderna and Novavax on June 15th at the 182 Meeting of the Vaccine and Related Biological Products Advisory Committee to select the next strain of SARS-CoV-2 to focus on development of the next COVID-19 antibody. The presentations demonstrated that the bivalent vaccines based on the Wuhan and BA.5/6 strains of SARS-CoV-2 produced very little neutralizing antibodies that recognized the XBB strains of the virus. Most people that were vaccinated in the last year produce antibodies that were poorly effective against the prevalent XBB strains. The question is whether the XBB strain that will be targeted now by vaccine manufacturers will be prominent in the next three months or replaced by another strain? https://www.youtube.com/watch?v=gBOyPREXGh8
__reactions__
New COVID-19 mRNA vaccine is safe and highly immunogenic as a heterologous booster
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.mRNA-based vaccines have emerged as a leading platform for COVID-19 protection and are extensively investigated in basic and clinical trials. SYS6006 (CSPC Pharmaceutical Group) is a newly investigational COVID-19 mRNA vaccine encoding a full-length S protein sequence of the prototype SARS-CoV-2 strain and incorporating the key mutations of main epidemic variants.
In March 2023, it has been authorized for emergent use in China by the national medicinal product agency (NMPA) of China. Yet, the data from clinical trials have not been published before. Moreover, the third dose of inactivated vaccine of COVID-19 has been proposed as the initial boosting regimen, and the second heterologous booster (the fourth dose of the vaccine) is worth investigating. By enrolling eligible healthy subjects and convalescent COVID-19 patients, researchers from Shanghai Xuhui Central Hospital have worked and unveiled the first clinical safety and efficacy profile of SYS6006.
These results demonstrated that a modified mRNA vaccine SYS6006 was safe and highly immunogenic as a heterologous booster in healthy Chinese adults. The strong enhancement of antibody titers after heterologous boosting is encouraging, along with the broad-spectrum neutralizing activity of these antibodies against variants of concern, such as Omicron BA.2 and BA.4/5. The titers in the SYS6006 group were higher than those in the convalescent patients. These findings suggest the flexible use of the mRNA vaccine as a booster regimen, which could accelerate the end of the pandemic...Read more
What are your thoughts on this study?
Physician assistants, associate physicians allowed to practise in P.E.I.
Tories promised to allow physician assistants to work in ERs. Health Minister Mark McLane announced the province has made the regulatory changes needed to allow associate physicians and physician assistants to practice in P.E.I.
Two new classifications of health workers – physician assistants and associate physicians – will be allowed to practice in P.E.I., although both will require the supervision of a doctor. The changes are effective as of June 17.
Physician assistants are clinicians who can perform a number of medical activities such as setting a fracture of a bone, administering drugs or vaccines and performing patient assessments...Read more
How do you feel about this decision?
CDC Panel Backs RSV Vaccine for Seniors

THURSDAY, June 22, 2023 (HealthDay News) -- An advisory panel of the U.S. Centers for Disease Control and Prevention voted on Wednesday to recommend the first RSV vaccines for seniors.
The U.S. Food and Drug Administration has already approved the vaccines, one made by GlaxoSmithKline called Arexvy and a version from Pfizer called Abrysvo.
During the meeting, the panel called for "shared clinical decision-making" between doctors and patients to discuss benefits and risks, but stopped short of recommending that all seniors get the shots.
Younger seniors, those in their early 60s, will have fewer risks for severe disease from the virus, CBS News reported. The vaccine trials did have a small number of very rare, but severe, "inflammatory neurologic events." CDC officials plan to closely follow data from vaccine safety systems as seniors begin getting the RSV vaccines.
"I want to remind everyone that we have one of the best vaccine safety systems in the world. We have the ability to rapidly acquire information, rapidly assess it and act on it. We saw that during the COVID pandemic, that system is viable and is in place," José Romero, M.D., director of the CDC National Center for Immunization and Respiratory Diseases, told the panel, CBS News reported.
Prices have not been finalized, but GSK has said its vaccine could carry a price tag of $200 to $295 per dose. Pfizer has said its shot will be between $180 and $270, CBS News reported.
Copyright © 2020 HealthDay. All rights reserved.